Atorvastatin versus rosuvastatin in acute myocardial infarction with elevated liver enzymes: a target trial emulation study

By sjmartinez • April 11, 2025

Chen X, Liu H, Li L, A G, Sun P, Tan DS, Chan MY, Foo RS, Fonarow GC, Yang Q, Zhou X. Atorvastatin versus rosuvastatin in acute myocardial infarction with elevated liver enzymes: a target trial emulation study. Clin Res Cardiol. 2025 Apr 10. doi: 10.1007/s00392-025-02645-0. Epub ahead of print. PMID: 40208301.

Tags: Atorvastatin, Cardiology/Epi, Elevated liver enzymes, mortality, myocardial infarction, Publications, Rosuvastatin

Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF

Koay YC, McIntosh B, Ng YH, Cao Y, Wang X, Han Y, Tomita S, Bai AY, Hunter B, Misra A, Loughrey CM, Bannon PG, Lal[...]

The Spatial Transcriptional Activity of Hepatic TCF7L2 Regulates Zonated Metabolic Pathways that Contribute to Liver Fibrosis

Ayala I, Hebbale SK, Mononen J, Brearley-Sholto MC, Shannon CE, Valdez I, Fourcaudot M, Bakewell TM, Zagorska A, Romero G, Asmis M, Musa FA, Sily[...]

Pathways and Molecular Mechanisms Governing LDL Receptor Regulation

Schmidt HM, Jarrett KE, de Aguiar Vallim TQ, Tarling EJ. Pathways and Molecular Mechanisms Governing LDL Receptor Regulation. Circ Res. 2025 Apr 11;136(8):902-919. doi: 10.1161/CIRCRESAHA.124.323578.[...]